Newsroom
February 1, 2023
The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was the lead site for a study evaluating Phase I and Phase III clinical trials for elacestrant, a treatment for postmenopausal women and adult men with ER+/HER2- advanced or metastatic breast cancer. The U.S. Food and Drug Administration on Jan. 27 announced it approved the […]
January 27, 2023
Yasmin Lyons, DO, Obstetrics & Gynecology, Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was interviewed live for this news segment. Read More
January 24, 2023
Basic science generates new drug for treating glioblastoma, the deadliest cancer Glioblastoma multiforme (GBM) is an aggressive brain cancer associated with the worst overall survival rates among all human cancers. Only 65% of GBM patients live one year past diagnosis and only 12% live five years. The late senators Ted Kennedy and John McCain both […]
January 24, 2023
Basic science generates new drug for treating glioblastoma, the deadliest cancer Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu Ryan Schoensee, 210-458-6054, ryan.schoensee@utsa.edu SAN ANTONIO (Jan. 24, 2023) — Glioblastoma multiforme (GBM) is an aggressive brain cancer associated with the worst overall survival rates among all human cancers. Only 65% of GBM patients live one year past diagnosis […]
December 21, 2022
Ratna K. Vadlamudi, PhD, vice chair for research, Obstetrics & Gynecology, co-leader of the Cancer Development and Progression Program, Mays Cancer Center, and Virginia Kaklamani, MD, Medical Oncology, leader of the Breast Cancer Program, Mays Cancer Center, were quoted in this piece. Read More
December 20, 2022
Philanthropist and Mays Cancer Center supporter Lowry Mays, and Jocelyn “Joci” Straus, the first chair of UT Health San Antonio, were included in this article. Read More